Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | RORA | P35398 | 1/20 | 0.34 |
| ▸ | RORC | P51449 | 1/20 | 0.34 |
| ▸ | RORB | Q92753 | 1/20 | 0.34 |
| ▸ | DNMT1 | P26358 | 3/20 | 0.32 |
| ▸ | PON1 | P27169 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | SRC | P12931 | 1/20 | 0.30 |
| ▸ | PRKACA | P17612 | 1/20 | 0.30 |
| ▸ | PRKACG | P22612 | 1/20 | 0.30 |
| ▸ | PRKACB | P22694 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24570766 | 0.91 | HTR1D (0.35) | HTR1DPGRRORARORCRORB | |
| SCHEMBL25758043 | 0.90 | HTR1D (0.38) | HTR1DPGRRORARORCRORB | |
| SCHEMBL25758070 | 0.88 | PGR (0.37) | HTR1DPGRRORARORCRORB | |
| SCHEMBL24570973 | 0.85 | PGR (0.32) | HTR1DPGRRORARORCRORB | |
| SCHEMBL25758015 | 0.85 | HTR1D (0.38) | HTR1DPGRRORARORCRORB | |
| SCHEMBL24494743 | 0.83 | HTR1D (0.38) | HTR1DPGRRORARORCRORB | |
| SCHEMBL20857914 | 0.83 | HTR1D (0.40) | HTR1DPGRRORARORCRORB | |
| SCHEMBL20857858 | 0.83 | HTR1D (0.41) | HTR1DPGRRORARORCRORB | |
| SCHEMBL24276377 | 0.82 | HTR1D (0.38) | HTR1DPGRRORARORCRORB | |
| SCHEMBL20857990 | 0.82 | HTR1D (0.39) | HTR1DPGRRORARORCRORB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230217819-A1 | LIGHT EMITTING ELEMENT AND POLYCYCLIC COMPOUND FOR LIGHT EMITTING ELEMENT | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
| US-20230217819-A1 | LIGHT EMITTING ELEMENT AND POLYCYCLIC COMPOUND FOR LIGHT EMITTING ELEMENT | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230217819-A1 | LIGHT EMITTING ELEMENT AND POLYCYCLIC COMPOUND FOR LIGHT EMITTING ELEMENT | NFE2L2, NR2E3, CCNE2 | HTR1D 2856/4885PGR 858/4885RORA 908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.